Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Spatio-temporal control of oncogenesis]

M Giovannini1

  • 1INSERM U434 Génétique des Tumeurs Fondation Jean Dausset, CEPH, Paris, France.

Pathologie-Biologie
|October 14, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of food portion size in children from 6 months to 8 years of age: a descriptive analysis.

European journal of nutrition·2026
Same author

Regional disparities in access to epinephrine auto-injectors for children and adults in Italy.

European annals of allergy and clinical immunology·2026
Same author

Otitis Media With Effusion (OME) and Eustachian Tube Dysfunction: The Role of Allergy and Immunity-An EAACI Position Paper.

Allergy·2025
Same author

Impact of Allergic Rhinitis on Academic Performance in Adolescents and Adults: a Bayesian Analysis of MASK-air® Real-world Direct Patient Data.

Journal of investigational allergology & clinical immunology·2024
Same author

EUS-guided transenteric pancreatic duct drainage.

Best practice & research. Clinical gastroenterology·2022
Same author

[Place of 3D custom-made implants after failure of modeling steno-chondro-plasties].

Annales de chirurgie plastique et esthetique·2022

This study introduces a novel modular transgenic mouse model for studying the neurofibromatosis type 2 (NF2) tumor suppressor gene. This advanced model allows for precise, time-controlled, tissue-specific gene inactivation to better understand tumor development.

Area of Science:

  • Oncology
  • Genetics
  • Developmental Biology

Context:

  • Traditional animal models for cancer research have limitations in mimicking human tumorigenesis.
  • Transgenic mouse models offer advancements but face challenges with specific human tumor types and early developmental lethality due to tumor suppressor gene inactivation.

Purpose:

  • To develop a modular transgenic mouse model for the tissue-specific inactivation of the neurofibromatosis type 2 (NF2) tumor suppressor gene.
  • To overcome limitations of existing models by enabling regulated, temporal, and spatial control over gene manipulation.

Summary:

  • A novel conditional knock-out mouse model was created for the NF2 tumor suppressor gene.
  • This model utilizes site-specific recombination (Cre-loxP) and inducible regulatory systems for precise control over somatic mutations.

Related Experiment Videos

  • Mutations can be induced in specific tissues at investigator-determined times, allowing detailed analysis of tumor initiation and progression.

    • Impact:

    • Provides a flexible and sophisticated tool for in-depth investigation of tumor initiation and progression.
    • Enhances the study of neurofibromatosis type 2 (NF2) and other cancers by enabling more accurate modeling of human disease.
    • Facilitates research into the temporal dynamics of genetic mutations in cancer development.